# Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test

> **NCT04904510** · — · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 297 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** INDICAID™ COVID-19 Rapid Antigen Test

## Key facts

- **NCT ID:** NCT04904510
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-20
- **Primary completion:** 2021-03-09
- **Final completion:** 2021-03-09
- **Target enrollment:** 297 (ACTUAL)
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04904510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04904510, "Evaluation of the INDICAID™ COVID-19 Rapid Antigen Test". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04904510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*